Among cotreated groups, thymic tumour incidences were not different between genotypes but did significantly decrease by ~3-fold among PPARγ-WT mice compared to their respective DMBA Only-treated PPARγ-WT controls (p < 0.05). Here, PPARG is linked to neoplasm.